scispace - formally typeset
S

Sneha S. Kelkar

Researcher at Wake Forest University

Publications -  23
Citations -  1373

Sneha S. Kelkar is an academic researcher from Wake Forest University. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 9, co-authored 14 publications receiving 1188 citations. Previous affiliations of Sneha S. Kelkar include Wake Forest Institute for Regenerative Medicine & Virginia Tech.

Papers
More filters
Journal ArticleDOI

Theranostics: Combining Imaging and Therapy

TL;DR: The creative approaches being developed for these classes of therapies and imaging modalities are discussed, and the recent developments along with examples of technologies that hold promise for the future of cancer medicine are highlighted.
Journal ArticleDOI

Indocyanine Green-Loaded Nanoparticles for Image-Guided Tumor Surgery

TL;DR: A series of hyaluronic acid-derived nanoparticles that entrap the near-infrared dye indocyanine green, termed NanoICG, for improved delivery of the dye to tumors and was found to be nontoxic at physiologically relevant concentrations and exposure was not found to inhibit cell growth.
Journal ArticleDOI

Near Infrared Fluorescent Nanoparticles Derived from Hyaluronic Acid Improve Tumor Contrast for Image-Guided Surgery

TL;DR: The efficacy of a panel of HA-derived NPs in delineating tumors in vivo is demonstrated, and promising formulations that can be used for future in vivo tumor removal efficacy studies are identified.
Journal ArticleDOI

Near infrared fluorescent nanoparticles based on hyaluronic acid: Self-assembly, optical properties, and cell interaction

TL;DR: It is shown that the impact of HA molecular weight and the hydrophobic moiety conjugation degree on fluorescence and cell interaction can be predicted and lay the foundation for selection of optimized HA-derived NPs for image-guided surgery.
Journal ArticleDOI

Development of a Self-Assembled Nanoparticle Formulation of Orlistat, Nano-ORL, with Increased Cytotoxicity against Human Tumor Cell Lines

TL;DR: NP formulation of ORL using HA-derived polymers retains similar levels of FASN, lipid synthesis, and ATP turnover inhibition while significantly improving the cytotoxic activity against cancer cell lines.